欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0241/002
药品名称Prazitel Plus XL Tablets
活性成分
    • febantel 525.0 mg
    • praziquantel 175.0 mg
    • pyrantel embonate 504.0 mg
剂型Tablet
上市许可持有人Chanelle Pharmaceuticals Manufacturing Limited Loughrea Co. Galway
参考成员国 - 产品名称Ireland (IE)
Prazitel Plus XL Tablets for Dogs
互认成员国 - 产品名称
    • Germany (DE)
      Prazitel Plus XL Tablets
    • Denmark (DK)
      Prazitel Forte Vet
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
      Prazitel Plus XL Tablets
    • Spain (ES)
      Prazitel Comprimidos para perros Grandes
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
      Prazitel Plus XL
    • Lithuania (LT)
    • Hungary (HU)
    • Bulgaria (BG)
    • Slovakia (SK)
许可日期2012/06/27
最近更新日期2023/06/13
药物ATC编码
    • QP52AF02 pyrantel
    • QP52AC05 febantel
    • QP52AA01 praziquantel
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase